Anti-Lyn (phospho Y397) antibody
3
(1 Review)
|
(7 Publications)
Rabbit Polyclonal LYN phospho Y397 antibody. Suitable for WB and reacts with Human samples. Cited in 7 publications. Immunogen corresponding to Synthetic Peptide within Human LYN phospho Y397.
View Alternative Names
JTK8, LYN, Tyrosine-protein kinase Lyn, Lck/Yes-related novel protein tyrosine kinase, V-yes-1 Yamaguchi sarcoma viral related oncogene homolog, p53Lyn, p56Lyn
- WB
Supplier Data
Western blot - Anti-Lyn (phospho Y397) antibody (AB226778)
10% SDS-PAGE gel.
All lanes:
Western blot - Anti-Lyn (phospho Y397) antibody (ab226778) at 1/500 dilution
Lane 1:
K562 (human chronic myelogenous leukemia cell line from bone marrow) whole cell extract at 30 µg
Lane 2:
K562 (human chronic myelogenous leukemia cell line from bone marrow) treated with CIP (calf-intestinal alkaline phosphatase), whole cell extract at 30 µg
Predicted band size: 59 kDa
false
- WB
CiteAb
Western blot - Anti-Lyn (phospho Y397) antibody (AB226778)
Lyn (phospho Y397) western blot using anti-Lyn (phospho Y397) antibody ab226778. Publication image and figure legend from Hoang, K. V., Rajaram, M. V. S., et al., 2018, Front Immunol, PubMed 29632532.
ab226778 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab226778 please see the product overview.
Dok-1 is phosphorylated during infection with serum-opsonized Schu S4 and co-localizes with Ras GTPase-activating protein (RasGAP). Monocyte-derived macrophage monolayers were infected with non-opsonized or pre-opsonized bacteria (MOI of 100). Infection was synchronized at 4°C followed by incubation at 37°C. At the indicated time points, cell lysates were collected and subjected to Western blot for phosphorylated Lyn and Dok-1 (A). Phosphorylated Dok-1/actin band intensity ratio at different time points from (A) is shown in (D). Association of RasGAP with phosphorylated Dok-1 was examined by immunoprecipitation using anti-RasGAP Ab (B). Phosphorylated Dok-1/RasGAP band intensity ratio at different time points from (B) is shown in (D). Data from (A) and (B) are representative of 3 independent experiments. Co-localization of RasGAP with Dok-1 was examined at the 5 min time point by confocal microscopy (C). Data are representative photomicrographs from three independent experiments.
false
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
As a regulator in signal transduction Lyn kinase is involved in the formation of protein complexes that modulate cell activation and proliferation. It participates in the phosphorylation of downstream substrates which leads to the initiation of various cellular responses. Lyn modulates pathways involving inflammation and immune responses impacting the development and function of immune cells. It is important for balancing activation and inhibition signals in the immune system ensuring a controlled immune response.
Pathways
Lyn kinase interacts with the B-cell receptor (BCR) signaling pathway and the Fc epsilon RI signaling pathway in mast cells. It associates with other Src family kinases like Fyn and Lck to regulate BCR signaling which influences B-cell development and differentiation. Lyn also acts upstream of pathways that control the release of inflammatory mediators. Through its role in these pathways Lyn indirectly impacts downstream processes and affects cellular communication and immune system homeostasis.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (7)
Recent publications for all applications. Explore the full list and refine your search
Signal transduction and targeted therapy 10:280 PubMed40887473
2025
Applications
Unspecified application
Species
Unspecified reactive species
Bone research 11:17 PubMed36928396
2023
Applications
Unspecified application
Species
Unspecified reactive species
British journal of pharmacology 178:4069-4084 PubMed34131920
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cancer cell 39:380-393.e8 PubMed33689703
2021
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 9:17210 PubMed31748641
2019
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports 25:3674-3692.e10 PubMed30590041
2018
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in immunology 9:561 PubMed29632532
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com